AU2002349295A1 - Glucose dependant release of insulin from glucose sensing insulin derivatives - Google Patents
Glucose dependant release of insulin from glucose sensing insulin derivativesInfo
- Publication number
- AU2002349295A1 AU2002349295A1 AU2002349295A AU2002349295A AU2002349295A1 AU 2002349295 A1 AU2002349295 A1 AU 2002349295A1 AU 2002349295 A AU2002349295 A AU 2002349295A AU 2002349295 A AU2002349295 A AU 2002349295A AU 2002349295 A1 AU2002349295 A1 AU 2002349295A1
- Authority
- AU
- Australia
- Prior art keywords
- glucose
- insulin
- derivatives
- dependant release
- sensing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200101784 | 2001-12-02 | ||
DKPA200101784 | 2001-12-02 | ||
US33703301P | 2001-12-05 | 2001-12-05 | |
US60/337,033 | 2001-12-05 | ||
PCT/DK2002/000804 WO2003048195A2 (en) | 2001-12-02 | 2002-12-02 | Glucose dependant release of insulin from glucose sensing insulin derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002349295A8 AU2002349295A8 (en) | 2003-06-17 |
AU2002349295A1 true AU2002349295A1 (en) | 2003-06-17 |
Family
ID=26069103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002349295A Abandoned AU2002349295A1 (en) | 2001-12-02 | 2002-12-02 | Glucose dependant release of insulin from glucose sensing insulin derivatives |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1453860A2 (en) |
JP (1) | JP2005526009A (en) |
AU (1) | AU2002349295A1 (en) |
WO (1) | WO2003048195A2 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004002534A1 (en) * | 2002-06-27 | 2004-01-08 | Novo Nordisk A/S | Use of dimethyl sulfone as isotonicity agent |
WO2007096431A1 (en) * | 2006-02-27 | 2007-08-30 | Novo Nordisk A/S | Insulin derivatives |
BRPI0717098B8 (en) | 2006-09-22 | 2021-05-25 | Novo Nordisk As | protease-resistant human insulin analogues, pharmaceutical composition and process for their preparation |
JP5496082B2 (en) | 2007-04-30 | 2014-05-21 | ノボ・ノルデイスク・エー/エス | Method for drying protein composition, dry protein composition, and pharmaceutical composition containing dry protein |
EP2254905B1 (en) | 2008-03-14 | 2016-12-14 | Novo Nordisk A/S | Protease-stabilized insulin analogues |
BRPI0910348B1 (en) | 2008-03-18 | 2021-06-29 | Novo Nordisk A/S | INSULIN STABILIZED IN ACILLED PROTEASE, PHARMACEUTICAL COMPOSITION INCLUDING IT AND ITS USES |
MA33064B1 (en) * | 2009-01-28 | 2012-02-01 | Smartcells Inc | Concomitant drug control management system |
EP2448962B1 (en) | 2009-06-30 | 2016-10-19 | Novo Nordisk A/S | Insulin derivatives |
TWI507462B (en) * | 2010-01-25 | 2015-11-11 | 羅門哈斯電子材料有限公司 | Photoresist comprising nitrogen-containing compound |
BR112014010139A2 (en) * | 2011-10-27 | 2017-04-25 | Univ Case Western Reserve | pharmaceutical formulation, method of reducing a patient's blood sugar level and polypeptide |
KR20150002777A (en) | 2012-04-11 | 2015-01-07 | 노보 노르디스크 에이/에스 | Insulin formulations |
US9867869B2 (en) | 2012-12-12 | 2018-01-16 | Massachusetts Institute Of Technology | Insulin derivatives for diabetes treatment |
WO2014161952A1 (en) | 2013-04-05 | 2014-10-09 | Novo Nordisk A/S | Dose logging device for a drug delivery device |
ES2676065T3 (en) | 2013-10-07 | 2018-07-16 | Novo Nordisk A/S | New derivative of an insulin analog |
AR099569A1 (en) | 2014-02-28 | 2016-08-03 | Novo Nordisk As | INSULIN DERIVATIVES AND THE MEDICAL USES OF THESE |
CN107530405A (en) * | 2015-03-13 | 2018-01-02 | 卡斯西部储备大学 | Insulin analog containing the glycoregulatory comformational switch of grape |
MX2018014929A (en) | 2016-06-02 | 2019-08-26 | Sanofi Sa | Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein. |
TW201831504A (en) * | 2016-11-21 | 2018-09-01 | 美國凱斯西方瑞瑟夫大學 | Rapid-acting insulin analogues of enhanced stability |
CA3045882A1 (en) | 2016-12-05 | 2018-06-14 | North Carolina State University | Core-shell microneedle devices and uses thereof |
IL300839B2 (en) | 2016-12-16 | 2024-04-01 | Novo Nordisk As | Insulin containing pharmaceutical compositions |
JP7254792B2 (en) | 2017-11-09 | 2023-04-10 | ノヴォ ノルディスク アー/エス | glucose-sensitive albumin-binding derivative |
WO2019106122A1 (en) | 2017-12-01 | 2019-06-06 | Sanofi | Novel conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein |
US20210214412A1 (en) * | 2018-04-16 | 2021-07-15 | University Of Utah Research Foundation | Glucose-responsive insulin |
TW202112397A (en) * | 2019-03-29 | 2021-04-01 | 丹麥商諾佛.儂迪克股份有限公司 | Glucose sensitive insulin derivatives |
JP2022543586A (en) * | 2019-07-31 | 2022-10-13 | サーマリン インコーポレイテッド | Insulin analogues with glucose-regulated conformational switches |
WO2021202802A1 (en) * | 2020-03-31 | 2021-10-07 | Protomer Technologies Inc. | Conjugates for selective responsiveness to vicinal diols |
PE20231948A1 (en) * | 2020-11-19 | 2023-12-05 | Protomer Tech Inc | AROMATIC COMPOUNDS CONTAINING BORON AND INSULIN ANALOGUES |
JPWO2022154055A1 (en) * | 2021-01-13 | 2022-07-21 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU628674B2 (en) * | 1989-10-19 | 1992-09-17 | Nippon Oil And Fats Company, Limited | Polymer complexes of a sugar response type |
CA2370302A1 (en) * | 1999-04-27 | 2000-11-02 | Benjamin Lee Hughes | Insulin crystals for pulmonary administration |
EP1290024A1 (en) * | 2000-06-02 | 2003-03-12 | Novo Nordisk A/S | Glucose dependent release of insulin from glucose sensing insulin derivatives |
-
2002
- 2002-12-02 WO PCT/DK2002/000804 patent/WO2003048195A2/en active Application Filing
- 2002-12-02 JP JP2003549382A patent/JP2005526009A/en not_active Withdrawn
- 2002-12-02 AU AU2002349295A patent/AU2002349295A1/en not_active Abandoned
- 2002-12-02 EP EP02781167A patent/EP1453860A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1453860A2 (en) | 2004-09-08 |
AU2002349295A8 (en) | 2003-06-17 |
WO2003048195A3 (en) | 2004-03-25 |
JP2005526009A (en) | 2005-09-02 |
WO2003048195A2 (en) | 2003-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002349295A1 (en) | Glucose dependant release of insulin from glucose sensing insulin derivatives | |
AU2001263775A1 (en) | Glucose dependent release of insulin from glucose sensing insulin derivatives | |
AU2002303594A1 (en) | Thermography catheter | |
AU2002363005A1 (en) | Derivatives of uk-2a | |
AU7830400A (en) | Synthesis of insulin derivatives | |
AU2002248464A1 (en) | Stabilized insulin formulations | |
AU2002349676A1 (en) | 4-oxoquinoline derivatives | |
AU2002257497A1 (en) | Derivatives of exendin | |
AU2002330453A1 (en) | Crystals of hydroxynorephedrine derivative | |
AU2002330095A1 (en) | Flavonoids for treatment of diabetes | |
AU2002330717A1 (en) | Monosaccharide derivatives | |
AU2002258736A1 (en) | Acetate detecting sensor | |
AU2002359458A1 (en) | Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases | |
AU2002358715A1 (en) | Tetrahydrobenzfluorene derivatives | |
AU2002248355A1 (en) | Positive sensitive catheter | |
AU2003253701A1 (en) | 11-c-substituted derivatives of clarithromycin | |
AU2002247455A1 (en) | Thermography catheter | |
AU2001282428A1 (en) | Stabilized derivatives of ascorbic acid -3-phosphate | |
AU2002319106A1 (en) | Dpp-iv-inhibiting purine derivatives for the treatment of diabetes | |
AU2002238072A1 (en) | Intravascular temperature sensor | |
AU2002337178A1 (en) | Regulation of human glucose transporter | |
AU2002253588A1 (en) | Heterocyclic compound derivatives and medicines | |
AU2002244972A1 (en) | Novel imidazolidinedione derivatives and use thereof as drugs | |
AU2002238520A1 (en) | An infrared medical thermometer | |
AU2001276655A1 (en) | Derivatives of para-ethoxy-phenillactic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |